We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -15.00 | -0.91% | 1,636.00 | 1,638.00 | 1,639.00 | 1,661.50 | 1,635.50 | 1,656.50 | 4,329,161 | 16:35:12 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.69 | 67.46B |
From Apr 2019 to Apr 2024
--Hedge fund Elliott Management Corp. has amassed a multibillion-pound stake in British pharma company GlaxoSmithKline PLC, the Financial Times reports.
--Elliott's investment comes after shareholders' disappointment at the leadership of CEO Dame Emma Walmsley, who is breaking up the company starting next year by separating the consumer-health business and the vaccine division, according to the FT.
--GSK management is also being blamed for underperforming peers and lagging in the race to develop a Covid-19 vaccine, the FT reports.
--GSK shares are up 64.2 pence, or 5%, at 1,353.8 pence.
Full story: https://on.ft.com/3uK3MjU
Write to Barcelona editors at barcelonaeditors@dowjones.com
(END) Dow Jones Newswires
April 15, 2021 09:06 ET (13:06 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
